Timothy Laing, MD, will continue to represent the ACR in his third stint on the AMA’s Relative Value System Update Committee, helping determine the relative value of clinical services.
March Deadlines for 2019 MIPS Submission
The last day to submit Merit-Based Incentive Payment System data via the ACR RISE registry is March 16.
ACR Partners with Veteran Groups to Call for Dedicated Department of Defense Arthritis Funding
Twenty-five veteran organizations have signed a letter to Congress supporting the ACR’s request for dedicated DOD arthritis research funds.
The ACR Introduces New Reproductive Health Guideline
The evidence-based guideline includes contraceptive recommendations and suggestions for rheumatologists co-managing patients with obstetrician-gynecologists and other specialists.
Sports Doctors May Accidentally Prescribe Banned Steroids
(Reuters Health)—Sports physicians routinely prescribe corticosteroids to athletes for conditions, such as inflammation, asthma and allergies, but not all of them know which forms of these drugs are banned under anti-doping rules, a study suggests. The survey of 603 physicians from 30 countries found four in five prescribe oral corticosteroids to athletes, one of the…
China Approves Use of Tocilizumab for Coronavirus Patients
BEIJING (Reuters)—China will use a Roche Holding AG arthritis drug to treat some coronavirus patients in severe conditions, health authorities said on Wednesday, as the country seeks to build up treatment regimens to help the infected recover. Tocilizumab, sold by the Swiss pharma giant under the trade name Actemra, can be prescribed to coronavirus patients…
Epidemiology of Rheumatoid Arthritis May Be Changing
NEW YORK (Reuters Health)’Over the last three decades, there has been a significant decline in the incidence of rheumatoid factor (RF) positive rheumatoid arthritis (RA), while the overall incidence of RA has remained about the same, researchers report. “These trends may suggest changing serological profile of RA over time which may have implications for RA…
Phase 3 Results for Olokizumab in RA Patients
In a recent study, olokizumab proved safe and effective for treating the signs and symptoms of RA and improving patients’ physical function…
How Autoimmune & Non-Autoimmune Family Conditions Predict Rheumatoid Arthritis
New research has incorporated confounders, such as smoking, to build a clearer picture of family-related factors that may help predict who will develop rheumatoid arthritis…
As Lyme Disease Spreads Across the U.S., Stay Alert for Fatal Lyme Carditis
The reach of Lyme disease is expanding across the U.S., and cases may be under-reported. A recent CDC case report describes the experiences of two patients with fatal cases of Lyme carditis…
- « Previous Page
- 1
- …
- 214
- 215
- 216
- 217
- 218
- …
- 814
- Next Page »